Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T20:32:13.424Z.
Calculation as of: 2026-10-06T20:32:13.424Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 9bf447c1d5373d17b51517f64cfe8ce44e33b4ae98b3907fdc05662a19d62e0e
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Metagenomi, Inc. Common Stock
Market Cap
$38.78M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$38.61M
Operating Cash Flow Yield
1.68%
TTM Avg
21.41%
3Y Avg
13.95%
5Y Avg
10.59%
Market Cap
$37.93M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$36.21M
Operating Cash Flow Yield
N/A
TTM Avg
0.20%
3Y Avg
0.20%
5Y Avg
0.20%
Market Cap
$35.84M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$35.84M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$35.76M
Operating Cash Flow Yield
N/A
TTM Avg
53.98%
3Y Avg
44.70%
5Y Avg
26.51%
Market Cap
$41.83M
Operating Cash Flow Yield
2.63%
TTM Avg
2.14%
3Y Avg
3.12%
5Y Avg
3.12%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Metagenomi, Inc. Common Stock (MGX) | $38.78M | N/A | N/A | N/A | N/A |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.61M | 1.68% | 21.41% | 13.95% | 10.59% |
| Incannex Healthcare Limited (IXHL)vs › | $37.93M | N/A | N/A | N/A | N/A |
| Veru Inc. (VERU)vs › | $39.64M | N/A | 0.02% | 0.02% | 0.25% |
| EUDA Health Holdings Limited (EUDA)vs › | $36.21M | N/A | 0.20% | 0.20% | 0.20% |
| Elicio Therapeutics, Inc. (ELTX)vs › | $35.84M | N/A | N/A | N/A | N/A |
| Edesa Biotech, Inc. (EDSA)vs › | $35.84M | N/A | N/A | N/A | N/A |
| DocGo Inc. (DCGO)vs › | $35.76M | N/A | 53.98% | 44.70% | 26.51% |
| Precipio, Inc. (PRPO)vs › | $41.83M | 2.63% | 2.14% | 3.12% | 3.12% |
| BioStem Technologies, Inc. (BSEM)vs › | $41.95M | N/A | 11.87% | 9.02% | 6.85% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
